ResearcherUniversity of California, IrvineActive in the last 2 years

Zigeng Zhang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039370100. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 2 papers

Papers 2

Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. Co-author DOI 10.21037/atm-23-1882 ↗
Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. First author DOI 10.3390/ijms252212038 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vahid Yaghmai · 2 shared papers, 2024 · strength 0.46
- Paper Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. DOI 10.21037/atm-23-1882 ↗
- Paper Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. DOI 10.3390/ijms252212038 ↗
Guangbo Yu · 2 shared papers, 2024 · strength 0.46
- Paper Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. DOI 10.21037/atm-23-1882 ↗
- Paper Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. DOI 10.3390/ijms252212038 ↗
Aydın Eresen · 2 shared papers, 2024 · strength 0.46
- Paper Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. DOI 10.21037/atm-23-1882 ↗
- Paper Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. DOI 10.3390/ijms252212038 ↗
Zhuoli Zhang · 2 shared papers, 2024 · strength 0.46
- Paper Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. DOI 10.21037/atm-23-1882 ↗
- Paper Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. DOI 10.3390/ijms252212038 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.